Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 44

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 44
---
 for the time period from his appointment to the Board in July 2024 to the date of the Annual Meeting when the restricted stock will vest. Information about the equity grants described in this footnote are included in the following table.

| Name             |     | Equity Award Type              |     |                |     | Grant Date  | Number ofUnits (#) |       |     | Grant DateFair Value ($) |        |        | Vesting Date |     |             |
| Susan E. Morano  |     | Restricted Stock               |     |                |     | May 9, 2024 |                    |       | 421 |                          | 31,000 |        | May 1, 2025  |     |             |
|                  |     | Deferred Restricted Stock Unit |     |                |     | May 9, 2024 |                    |       | 421 |                          |        | 31,000 | May 1, 2025  |     |             |
| Cheryl Pegus     |     | Deferred Restricted Stock Unit |     | June 3, 2024   |     |             |                    |   407 |     |                          |        | 31,000 |              |     | May 1, 2025 |
| David C. Habiger |     | Restricted Stock               |     | August 1, 2024 |     |             |                    | 1,252 |     |                          |        | 94,000 |              |     | May 1, 2025 |

(4) Each non-employee director elected at our 2024 Annual Meeting of Stockholders was granted an equity award with a value of $215,000. For each director who elected to receive a restricted stock award, the restricted stock award vests on the date of the annual meeting of stockholders immediately following the date of grant, subject to the director’s continued service during such term. For each director who elected to receive deferred restricted stock units, the deferred restricted stock units vest on the date of the annual meeting of stockholders immediately following the date of grant, subject to continued service during such term, and vested shares of stock will be issued to the director upon his or her separation from Board service in accordance with the Non-Employee Director Deferred Compensation Plan. The awards to Dr. Pegus and Mr. Habiger represent the annual equity

#### 2025 Proxy Statement37

#### Director Compensation
award for the 2024 term prorated for the period